The SPIRIT V study: a clinical evaluation of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with de novo coronary artery lesions

Abstract

The SPIRIT V (A Clinical Evaluation of the XIENCE V Everolismus-Eluting Coronary Stent System in the Treatment of Patients With De Novo Coronary Artery Lesions) is a post-marker surveillance experience of the XIENCE V (Abbott Vascular, Santa Clara, California) everolimus-eluting stent (EES) in patients with higher-risk coronary anatomy.

Keywords

• drug-eluting stent (DES)
• everolimus
• percutaneous coronary intervention (PCI)
• stent